SCHIFF BASES AS MULTIFUNCTIONAL SCAFFOLDS: UNLOCKING PHARMACOLOGICAL VERSATILITY IN DRUG DESIGN

Schiff bases are an important group of imine derivatives containing the characteristic azomethine (–C=N–) linkage. Their facile synthesis, structural versatility, and scope for chemical modification have made them attractive candidates in medicinal chemistry and drug discovery. This review summarizes the major synthetic strategies, structure–activity relationships, pharmacological properties, limitations, and emerging applications of Schiff bases, with particular emphasis on their multifunctional therapeutic potential. Conventional as well as environmentally sustainable synthetic approaches, including microwave-assisted techniques, are discussed. The biological activities of Schiff bases derivatives have been investigated in several therapeutic areas, including antimalarial, anti-inflammatory, antioxidant, anti-Alzheimer's, anticancer, antibacterial, antifungal, and antidiabetic applications. The effect of structural substituents, electronic characteristics, molecular modifications, and metal coordination on their biological performance is also highlighted. In addition, computational approaches such as molecular docking and ADMET prediction have contributed to the identification and optimization of promising Schiff base derivatives. Nevertheless, issues including limited aqueous solubility, inadequate bioavailability, chemical instability, possible toxicity, and insufficient long-term and clinical investigations continue to restrict their progression toward therapeutic applications. Future research integrating sustainable chemistry, computational drug design, artificial intelligence, and nanotechnology-based drug delivery could help overcome these challenges and improve the pharmacological potential of Schiff base compounds. Overall, Schiff bases offer a promising and adaptable chemical framework for the development of multifunctional therapeutic agents, although comprehensive preclinical and clinical studies are necessary to establish their safety, efficacy, and translational potential.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-04
DOI
https://doi.org/10.5281/zenodo.23940231
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SCHIFF BASES AS MULTIFUNCTIONAL SCAFFOLDS: UNLOCKING PHARMACOLOGICAL VERSATILITY IN DRUG DESIGN

Siju Ellickal Narayanan, Hariraj Narayanan, Sneha Raj, Mubashir Gafoor Vettathur et al.
Zenodo (CERN European Organization for Nuclear Research)
Heterocyclic Compound Synthesis and Bioactivity
article

SCHIFF BASES AS MULTIFUNCTIONAL SCAFFOLDS: UNLOCKING PHARMACOLOGICAL VERSATILITY IN DRUG DESIGN

Siju Ellickal Narayanan, Hariraj Narayanan, Sneha Raj, Mubashir Gafoor Vettathur, Anupama Peroth Vidhyadharan
article en

Abstract

Schiff bases are an important group of imine derivatives containing the characteristic azomethine (–C=N–) linkage. Their facile synthesis, structural versatility, and scope for chemical modification have made them attractive candidates in medicinal chemistry and drug discovery. This review summarizes the major synthetic strategies, structure–activity relationships, pharmacological properties, limitations, and emerging applications of Schiff bases, with particular emphasis on their multifunctional therapeutic potential. Conventional as well as environmentally sustainable synthetic approaches, including microwave-assisted techniques, are discussed. The biological activities of Schiff bases derivatives have been investigated in several therapeutic areas, including antimalarial, anti-inflammatory, antioxidant, anti-Alzheimer's, anticancer, antibacterial, antifungal, and antidiabetic applications. The effect of structural substituents, electronic characteristics, molecular modifications, and metal coordination on their biological performance is also highlighted. In addition, computational approaches such as molecular docking and ADMET prediction have contributed to the identification and optimization of promising Schiff base derivatives. Nevertheless, issues including limited aqueous solubility, inadequate bioavailability, chemical instability, possible toxicity, and insufficient long-term and clinical investigations continue to restrict their progression toward therapeutic applications. Future research integrating sustainable chemistry, computational drug design, artificial intelligence, and nanotechnology-based drug delivery could help overcome these challenges and improve the pharmacological potential of Schiff base compounds. Overall, Schiff bases offer a promising and adaptable chemical framework for the development of multifunctional therapeutic agents, although comprehensive preclinical and clinical studies are necessary to establish their safety, efficacy, and translational potential.

Zenodo (CERN European Organization for Nuclear Research)
Government of Kerala (IN), Kerala University of Health Sciences (IN), Kannur Medical College (IN)
Openalex Percentile: Top 27%
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon